Case Report
Year 2016,
Volume: 1 Issue: 2, 6 - 11, 13.12.2016
Abstract
AA amyloidosis is a form of amyloidosis encountered in chronic inflammatory diseases. At the present
time, its most common cause is rheumatic diseases. The incidence of amyloidosis is % 3- 6 in Rheumatoid
arthritis, 11%-13% in the Familial Mediterranean fever and % 1- 3 in inflammatory bowel disease. In
this report, the treatment of FMF and juvenile idiopathic arthritis concomitant with amyloidosis was
discussed with current literature.
References
- 1. Comak E, Dogan CS, Akman S, Koyun M, Gokceoglu AU, Keser I. MEFV gene mutations in Turkish children with juvenile idiopathic arthritis. European Journal of Pediatrics. August 2013; 172(8): 1061-67.
- 2. De La Torre M, Arboleya L, Pozo S, Pinto J, Velasco J. Rapid and sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in a patient with nephrotic syndrome secondary to systemic juvenile idiopathic arthritis-related amyloidosis. NDT Plus (2011) 4: 178-80.
- 3. Düşünsel R, Dursun İ, Gündüz Z, Poyrazoğlu M. H, Gürgöze M.K, Koç. A, R. Anarat. Juvenil idiopatik artritli çocuklarda böbrek fonksiyonları. Erciyes Tıp Dergisi 2007; 29(1): 25-30.
- 4. Faik RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997; 337(13): 898-09.
- 5. Gilgil E, Arman Mİ. Ailesel Akdeniz Ateşi. In: Göksoy T. (ed). Romatizmal Hastalıkların Tanı ve Tedavisi. Antalya: Yüce Yayım 2002: 59; 711-9.
- 6. Greenstein AJ, Sachar DB, Panday AK, Dikman SH, Meyers S, Heimann T, Gumaste V, Werther JL, Janowitz HD. Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine 1992; 71(5): 261-70.
- 7. Myllykangas-Luosujarvi R, Aho K, Kautiainen H, M. Hakala. Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology (Oxford). 1999; 38(6): 499-03.
- 8. Nagihara K, Kagawa S, Kishida Y, Arimitsu j. Anti-Cytokine Therapy for AA Amyloidosis. In: Feng D. Editor. Amyloidosis. ISBN 978-953-51-1100-9, Published: June 12, 2013.
- 9. Rozenbaum M, Rosner I. Severe outcome of juvenile idiopathic arthritis associated with familial Mediterranean fever. Clin Exp Rheumatol. 2004; Jul-Aug; 22(4 Suppl 34): 75-8.
- 10. Seldin D.C, Skinner M. Amiloidoz. In: Fauci A.S, editor. Harrison Romatoloji. 2th ed. İstanbul, CN: Nobel Tıp Kitapevi Tic. Ltd. Şti; 2013.
- 11. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E. Familial Mediterranean fever (FMF) in Turkey: results of a nation wide multi center study. Medicine. 2005; 84(1):1-11.
Year 2016,
Volume: 1 Issue: 2, 6 - 11, 13.12.2016
Abstract
AA amiloidoz, kronik inflamatuar hastalıklardaki amiloidoz türüdür. Günümüzde en sık nedeni romatizmal
hastalıklardır. Amiloidoz, Romatoid artritte (RA) % 3-6, Ailevi Akdeniz Ateşinde (AAA) % 11-
13, İnflamatuar Barsak Hastalığında %1-3 oranında saptanmıştır. Burada AAA ve Juvenil İdiopatik
Artrit (JİA) olan amiloidozlu bir olgunun tedavisi güncel literatür eşliğinde tartışılmıştır.
References
- 1. Comak E, Dogan CS, Akman S, Koyun M, Gokceoglu AU, Keser I. MEFV gene mutations in Turkish children with juvenile idiopathic arthritis. European Journal of Pediatrics. August 2013; 172(8): 1061-67.
- 2. De La Torre M, Arboleya L, Pozo S, Pinto J, Velasco J. Rapid and sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in a patient with nephrotic syndrome secondary to systemic juvenile idiopathic arthritis-related amyloidosis. NDT Plus (2011) 4: 178-80.
- 3. Düşünsel R, Dursun İ, Gündüz Z, Poyrazoğlu M. H, Gürgöze M.K, Koç. A, R. Anarat. Juvenil idiopatik artritli çocuklarda böbrek fonksiyonları. Erciyes Tıp Dergisi 2007; 29(1): 25-30.
- 4. Faik RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997; 337(13): 898-09.
- 5. Gilgil E, Arman Mİ. Ailesel Akdeniz Ateşi. In: Göksoy T. (ed). Romatizmal Hastalıkların Tanı ve Tedavisi. Antalya: Yüce Yayım 2002: 59; 711-9.
- 6. Greenstein AJ, Sachar DB, Panday AK, Dikman SH, Meyers S, Heimann T, Gumaste V, Werther JL, Janowitz HD. Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine 1992; 71(5): 261-70.
- 7. Myllykangas-Luosujarvi R, Aho K, Kautiainen H, M. Hakala. Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology (Oxford). 1999; 38(6): 499-03.
- 8. Nagihara K, Kagawa S, Kishida Y, Arimitsu j. Anti-Cytokine Therapy for AA Amyloidosis. In: Feng D. Editor. Amyloidosis. ISBN 978-953-51-1100-9, Published: June 12, 2013.
- 9. Rozenbaum M, Rosner I. Severe outcome of juvenile idiopathic arthritis associated with familial Mediterranean fever. Clin Exp Rheumatol. 2004; Jul-Aug; 22(4 Suppl 34): 75-8.
- 10. Seldin D.C, Skinner M. Amiloidoz. In: Fauci A.S, editor. Harrison Romatoloji. 2th ed. İstanbul, CN: Nobel Tıp Kitapevi Tic. Ltd. Şti; 2013.
- 11. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E. Familial Mediterranean fever (FMF) in Turkey: results of a nation wide multi center study. Medicine. 2005; 84(1):1-11.
There are 11 citations in total.
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Clinical Sciences |
| Journal Section | Articles |
| Authors | |
| Publication Date | December 13, 2016 |
| Published in Issue | Year 2016 Volume: 1 Issue: 2 |
